Presentation ESC 2016 Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With Non-ischemic Heart Failure Presenter: Javed Butler August 28, 2016 REGISTER for free or LOG IN to view this content Coronary Heart Failure Presentation ESC 2016 Up Next Presentation ESC 2016 ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications Presenter: Gilles Montalescot August 28, 2016 More slides + Presentation ESC 2016 CE-MARC 2 Trial: A Prospective, Multi-Centre, Randomized Trial Of 3 Diagnostic Strategies In Suspected Coronary Heart Disease (CMR vs UK NICE Guidelines vs MPS-SPECT) Presenter: John P. Greenwood August 29, 2016 Presentation ESC 2016 DOCTORS: Does Optical Coherence Tomography Optimise Results of Stenting? Presenter: Nicolas Meneveau August 29, 2016 We Recommend
Presentation ESC 2016 ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications Presenter: Gilles Montalescot August 28, 2016
Presentation ESC 2016 CE-MARC 2 Trial: A Prospective, Multi-Centre, Randomized Trial Of 3 Diagnostic Strategies In Suspected Coronary Heart Disease (CMR vs UK NICE Guidelines vs MPS-SPECT) Presenter: John P. Greenwood August 29, 2016
Presentation ESC 2016 DOCTORS: Does Optical Coherence Tomography Optimise Results of Stenting? Presenter: Nicolas Meneveau August 29, 2016